Identification of apoptotic proteins in thyroid gland from patients with Grave's desease and Hashimoto's thyroiditis

Autoimmunity

Volumn 41, Issue 2, 2008, Pages 163-173

  Bossowski, A ^a   Czarnocka, B ^b   Bardadin, K ^b   Stasiak Barmuta, A ^a   Urban, M ^a   Dadan, J ^a   Ratomski, K ^a   Bossowska, A ^c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c Division of Cardiology   (Poland)

Author keywords

Apoptosis; Caspase 8; Fas; FasL; Graves' disease

Indexed keywords

4 DIMETHYLAMINOAZOBENZENE; CASPASE 8; FAS ANTIGEN; FAS LIGAND; HEMATOXYLIN; LEVOTHYROXINE; PROPRANOLOL; THIAMAZOLE; THYROID HORMONE; THYROTROPIN RECEPTOR ANTIBODY;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; DRUG DOSE REDUCTION; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; MALE; NODULAR GOITER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; THYROID FOLLICLE CELL; THYROID GLAND; THYROID SURGERY; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIGENS, CD95; APOPTOSIS; CASPASE 8; CHILD; FAS LIGAND PROTEIN; FEMALE; GOITER, NODULAR; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; MALE; THYROID GLAND;

EID: 40649092106     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930701727749     Document Type: Article

References (30)

1. Salamaco, C., Bagnasco, M., Pesce, G., Montagna, P., Brizzolara, R., Altrinetti, V., Richiusa, P., Gallazzo, A. and Giordano, C. (2002) Regulation of apoptosis in endocrine autoimmunity. Ann NY Acad Sci, 966, pp. 496-501.
2. Vaux, D. and Flavell, RA (2000) Apoptosis genes and autoimmunity. Cur Opin Immunol, 12, pp. 719-724.
3. Andrikoula, M. and Tsatsoulis, A. (2001) The role of Fas-mediated apoptosis in thyroid disease. Eur J Endocrinol, 144, pp. 561-568.
4. Kroemer, G., Zamzami, N. and Susin, SA (1997) Mitochondria control of apoptosis. Immunol Today, 18, pp. 44-51.
5. Green, DR and Reed, JC (1998) Mitochondria and apoptosis. Science, 281, pp. 1309-1312.
6. Desagher, S. and Martinou, JC (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol, 10, pp. 369-377.
7. Tsatsoulis, A. (2002) The role of apoptosis in thyroid disease. Minerva Med, 93, pp. 169-180.
8. Mitsiades, N., Poulaki, V., Mitsiades, CS, Koutras, DA and Chrousos, GP (2001) Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases. Trends Endocrinol Metab, 12:9, pp. 384-390.
9. Giordano, C., Richiusa, P., Bagnasco, M., Pizzolanti, G., Blasi, F Di, Sbriglia, MS, Mattina, A., Pesce, G., Montagna, P., Capone, F., Misiano, G., Scorsone, A., Pugliese, A. and Galluzzo, A. (2001) Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid, 11:3, pp. 245-247.
10. Wei, Y., Chen, K., Sharp, GC, Yagita, H. and Braley-Mullen, H. (2001) Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatosus experimental autoimmune thyroiditis. J Immunol, 167, p. 6678.
11. Hiromatsu, Y., Hoshino, T., Yagita, H., Koga, M., Sakisaka, S., Honda, J., Yang, D., Kayagaki, N., Okumura, K. and Nonaka, K. (1999) Functional Fas ligand expression in thyrocytes from patients with Graves' disease. J Clin Endocrinol Metab, 84, pp. 2896-2902.
12. Kawakami, A. and Eguchi, K. (2002) Involvement of apoptotic cell death in autoimmune diseases. Med Electron Microsc, 35, pp. 1-8.
13. Rasmussen, AK, Feldt-Rasmussn, U., Brandt, M., Hartoft-Nielsen, ML, Carayon, P. and Buschard, K. (1999) Thyrotropin stimulates specifically the expression of the autoantibody binding domains of the thyroperoxidase molecule. Autoimmunity, 29:4, pp. 323-331.
14. Bossowski, A., Stasiak-Barmuta, A., Czarnocka, B., Urban, M. and Dadan, J. (2005) Application of mAbs for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometry. Autoimmunity, 38:8, pp. 1-7.
15. Stassi, G., Todaro, M., Bucchieri, F., Stoppacciaro, A., Farina, F., Zummo, G., Testi, R. and De Maria, R. (1999) Fas/Fas ligand-driven T cell apoptosis as a conseqence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. J Immunol, 162, pp. 263-267.
16. Weetman, AP and McGregor, AM (1994) Autoimmune thyroid disease: Further developments in our understanding. Endocr Rev, 15, pp. 788-830.
17. Costagliola, S., Many, MC, Denef, JF, Pohlenz, J., Refetoff, S. and Vassart, G. (2000) Genetic immunization of out bred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Incest, 105, pp. 803-811.
18. Pujol-Borrell, R., Todd, I., Londei, M., Feldmann, M. and Bottazzo, GF (1987) New ideas in thyroid autoimmunity. Horm Res, 26, pp. 118-124.
19. Baker Jr, JR (2001) The nature of apoptosis in the thyroid and the role it may play in autoimmune thyroid disease. Thyroid, 11, pp. 245-247.
20. Stassi, G., Zeuner, A., Liberto, D Di, Todaro, M., Ricci-Vitiani, L. and De Maria, R. (2001) Fas/FasL in Hashimoto's thyroiditis. J Clin Immunol, 21, pp. 19-23.
21. Giordano, C., Stassi, G., De Maria, R., Todaro, M., Richiusa, P., Papoff, G., Ruberti, G., Bagnasco, M., Testi, R. and Galluzzo, A. (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science, 275, pp. 960-963.
22. Heuer, M., Aust, G., Ode-Hakim, S. and Scherbaum, WA (1996) Different cytokines mRNA profiles in Graves' disease, Hashimoto's thyroiditis and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid, 6, pp. 97-106.
23. Stassi, G., Zeuner, A., Liberto, D Di, Todaro, M., Ricci-Vitiani, L. and De Maria, R. (2001) Fas/FasL in Hashimoto's thyroiditis. J Clin Immunol, 21, pp. 19-23.
24. Stassi, G. and De Maria, R. (2002) Autoimmune thyroid disease: New models of cell death in autoimmunity. Nat Rev Immunol, 2, pp. 195-204.
25. Kawakami, A., Eguchi, K., Matsuoka, N., Tsuboi, M., Urayama, S., Kawabe, Y., Tahara, K., Ishikawa, N., Ito, K. and Nagataki, S. (1997) Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema. Clin Exp Immunol, 110, pp. 434-439.
26. Mihara, S., Suzuki, N., Wakisaka, S., Suzuki, S., Sekita, N., Yamamoto, S., Saito, N., Hoshino, T. and Sakane, T. (1999) Effects of thyroid hormones on apoptotic cell death of human lymphocytes. J Clin Endocrinol Metab, 84, pp. 1378-1385.
27. De Maria, R. and Testi, R. (1998) Fas-FasL interactions: A common pathogenetic mechanizm in organ-specific autoimmunity. Immunol Today, 19, pp. 121-125.
28. Fisher, GH, Rosenberg, FJ, Straus, SE, Dale, JK, Middleton, LA, Lin, AY, Strober, W., Lenardo, MJ and Puck, JM (1995) Dominant interfering Fas gene mutations impair apoptosis in a human lymphoproliterative syndrome. Cell, 81, pp. 935-946.
29. Rieux-Laucat, F., Deist, F Le, Hivroz, C., Roberts, IA, Debatin, KM, Fischer, A. and de Villartay, JP (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science, 268, pp. 1347-1349.
30. Bona, G., Defranco, S., Chiocchetti, A., Indelicato, M., Biava, A., Difranco, D., Dianzani, I., Ramenghi, U., Corrias, A., Weber, G., De Sanctis, V., Iughetti, L., Radetti, G. and Dianzani, U. (2003) Defective function of Fas in T cells from paediatric patients with autoimmune thyroid diesases. Clin Exp Immunol, 133, pp. 430-437.